| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/28/2007 | CA2632021A1 Gaba-b receptor modulators |
| 06/28/2007 | CA2631347A1 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | CA2630889A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | CA2626220A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 06/27/2007 | EP1801165A2 Modified carbocyanine dyes and their conjugates |
| 06/27/2007 | EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 06/27/2007 | EP1799673A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 06/27/2007 | EP1799672A2 Cgrp receptor antagonists |
| 06/27/2007 | EP1799671A2 Chemical compounds |
| 06/27/2007 | EP1799669A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 06/27/2007 | EP1799668A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 06/27/2007 | EP1799652A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 06/27/2007 | EP1799651A2 Small molecule modulators of cytokine activity |
| 06/27/2007 | EP1799650A2 Imidazole derivatives as large conductance calcium activated k channel openers |
| 06/27/2007 | EP1799649A1 3-(2-hydroxyphenyl) pyrazoles and their use as hsp90 modulators |
| 06/27/2007 | EP1799639A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 06/27/2007 | EP1682532B1 Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k) |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1485376B1 Compositions useful as inhibitors of protein kinases |
| 06/27/2007 | CN1989130A Substituted diketopiperazines as oxytocin antagonists |
| 06/27/2007 | CN1989113A 喹唑啉衍生物 Quinazoline derivatives |
| 06/27/2007 | CN1989104A Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 06/26/2007 | USRE39708 Estrogen receptor modulators |
| 06/26/2007 | US7235580 Mitotic kinesin inhibitors |
| 06/26/2007 | US7235579 Antiinflammatory agents; antidepressants; respiratory system disorders; cognition activators |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/26/2007 | US7235562 5-trifluoromethyl-N2-indolyl- and quinolinyl-substituted-2,4-pyrimidinediamines, e.g., N2-[3-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-N4-p-tolyl-5-trifluoromethyl-pyrimidine-2,4-diamine and -[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-3,4-dihydro-1H-quinolin-2-one |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235559 Therapeutic quinazoline derivatives |
| 06/26/2007 | US7235555 Indolylmaleimide derivatives |
| 06/26/2007 | US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease |
| 06/26/2007 | US7235543 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/26/2007 | US7235537 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 06/26/2007 | CA2413037C Intermediates for producing antitumor indolopyrrolocarbazole derivatives |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2142309C Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007070556A2 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | WO2007070506A2 Diaza heterocyclic sulfonamide derivatives and their uses |
| 06/21/2007 | WO2007070398A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069053A1 Benzimidazole antagonists of the h-3 receptor |
| 06/21/2007 | WO2007068621A1 Novel fused pyrrole derivatives |
| 06/21/2007 | WO2007068375A1 Carboxamides for controlling undesired micro-organisms in plant protection |
| 06/21/2007 | WO2007048841A3 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 06/21/2007 | WO2007048064A3 Amino-pyrimidines as casein kinase ii (ck2) modulators |
| 06/21/2007 | WO2007039821A3 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics |
| 06/21/2007 | WO2007039117A3 A process for the preparation of sartan derivatives and intermediates useful in such process |
| 06/21/2007 | WO2007036532A3 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 06/21/2007 | WO2007022380A3 Bis-aryl amide compounds and methods of use |
| 06/21/2007 | WO2007003604A3 Hists1mine h3 receptor antagonists |
| 06/21/2007 | US20070142645 Method for the production of n,n-carbonyldiazoles |
| 06/21/2007 | US20070142641 Atazanavir conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070142634 phenylamide and pyridylamide derivative compounds having a terminal or branched amino or hydroxyl group |
| 06/21/2007 | US20070142453 1-Alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions |
| 06/21/2007 | US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor |
| 06/21/2007 | US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia |
| 06/21/2007 | US20070142436 New salt and polymorph of a DPP-IV inhibitor |
| 06/21/2007 | US20070142434 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 06/21/2007 | US20070142431 Quinoline 4-carboxamide derivatives and their use as neurokinin 3 (nk-3) receptor antagonists |
| 06/21/2007 | US20070142417 Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor |
| 06/21/2007 | US20070142416 Pyrimidinyl amide compounds with inhibit leukocyte adhesion mediated by VLA-4 |
| 06/21/2007 | US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases |
| 06/21/2007 | US20070142412 Crystalline form of 2-{4-['3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl]piperidin-1-yl}-2-oxoethanol |
| 06/21/2007 | US20070142409 3-Substituted-4-pyrimidone derivatives |
| 06/21/2007 | US20070142394 Substituted aniline derivatives useful as histamine H3 antagonists |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142391 Piperazine-2-carboxamide derivatives |
| 06/21/2007 | US20070142389 Piperidine derivatives |
| 06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
| 06/21/2007 | US20070142372 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/21/2007 | US20070142371 Anti-Cytokine Heterocyclic Compounds |
| 06/21/2007 | US20070142368 N4-(2-methoxyethyl)-N6-(5methyl-1H-pyrazol-3-yl)-2-styrylpyrimidine-4,6-diamine; Aurora protein kinase inhibitors; anticarcinogenic agents; antitumor agents; antimetastatic agents; melanoma, lymphoma, leukemia; cancer of the colon, colorectum, breast, lung, kidney, pancreas, kidney, stomach; ovaries |
| 06/21/2007 | US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC |
| 06/21/2007 | US20070142362 4,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators |
| 06/21/2007 | US20070142360 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | US20070142329 2-Chloro-N-[2-(2-chloro-phenyl)-ethyl]-5-(6-oxo-1,6-dihydro-pyrazin-3-yl)benzamide, for example; useful in the treatment of IL-1 mediated disorders, including inflammatory diseases such as osteoarthritis and rheumatoid arthritis, allergies, asthma, COPD, cancer |
| 06/21/2007 | US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R) |
| 06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
| 06/21/2007 | US20070142268 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/21/2007 | US20070142245 E.g., bis(1,2,3,4-tetrahydroquinolin-8-yl)amine, bis(2,3-dihydro-1-benzofuran-5-yl)amine and bis(1,3-benzodioxol-5-yl)amine; oil soluble and serve as antioxidants, antiozoants, heat stabilizers and ultraviolet light stabilizers |
| 06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 06/21/2007 | US20070140970 Cell targeting conjugates |
| 06/21/2007 | US20070140962 Light Sensitive Compounds for Instant Determination of Organ Function |
| 06/21/2007 | US20070138950 Nitrogenous heterocycle derivative and organic electroluminescent element employing the same |
| 06/21/2007 | CA2637740A1 Fused pyrrole derivatives |
| 06/21/2007 | CA2633569A1 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors |
| 06/21/2007 | CA2632027A1 Diaza heterocyclic sulfonamide derivatives and their uses |
| 06/20/2007 | EP1797073A2 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 06/20/2007 | EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 06/20/2007 | EP1797067A1 New heterocyclic amides |
| 06/20/2007 | EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 06/20/2007 | EP1797045A1 Novel pyrimidine derivatives and their use as ppar-alpha modulators |
| 06/20/2007 | EP1797042A1 Indozolone derivatives as 11b-hsd1 inhibitors |